Dr. Navid Seraji-Bozorgzad, MD

Dr. Seraji-Bozorgzad practices at University Hospital in Ann Arbor, Michigan.

Dr. Seraji-Bozorgzad's NPI, 1326238999, was assigned on July 30, 2007. Dr. Seraji-Bozorgzad graduated from Wayne State University School of Medicine in 2007. Dr. Seraji-Bozorgzad holds Michigan license 4301090546.

Dr. Seraji-Bozorgzad's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Seraji-Bozorgzad's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Seraji-Bozorgzad is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Seraji-Bozorgzad to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account. Dr. Seraji-Bozorgzad's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seraji-Bozorgzad practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Seraji-Bozorgzad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Seraji-Bozorgzad is licensed in Michigan.

CMS data shows 272 Medicare services from Dr. Seraji-Bozorgzad across 6 procedure codes in 2024, for 254 Medicare patients. Medicare paid $17,052 for them.

CMS counts 254 Medicare patients who saw Dr. Seraji-Bozorgzad in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seraji-Bozorgzad's median patient age at 70, with 57% women.

In 2024, Dr. Seraji-Bozorgzad wrote 1,243 Medicare Part D claims for 229 patients. 95% of them were for generic drugs. CMS names the drug for 1,109 of them, across 20 drugs with 11 or more claims each, at $35,910 in total drug cost. In 2023, CMS named 1,031 claims across 18 drugs.

Dr. Seraji-Bozorgzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seraji-Bozorgzad as offering telehealth.

Dmand AI links 18 papers to Dr. Seraji-Bozorgzad, published from 2016 to 2020. 2016 was the busiest year, with 3. The most frequent topics are Anticonvulsants, Diagnosis, Differential and Multiple Sclerosis. Dr. Seraji-Bozorgzad has published most often in Mult Scler Relat Disord. Dr. Seraji-Bozorgzad's most frequent co-authors are Evanthia Bernitsas, MD, Omar Khan, MD and Aashit Kanubhai Shah, MD.

CMS Open Payments shows 11 general payments to Dr. Seraji-Bozorgzad from 1 drug or device company in 2025. Consulting fees make up the largest share, 74% of the total. Siemens Medical Solutions USA, Inc. paid the most, $7,481.

Dr. Seraji-Bozorgzad graduated from Wayne State University School of Medicine in 2007.